Which Medical Device

BIOTRONIk announced the completion of enrollment in the BIOLUX P-I - a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy. Read more

Biotronik (Lake Oswego, OR) announced the release of its Passeo-18 Lux drug-releasing balloon (DRB) in all countries recognizing CE Mark. The device recently earned European CE Mark approval. The company stated that the Passeo-18 Lux is a novel combination device for treating de novo and restenotic femoropopliteal lesions. The device?s design is based on the company?s Passeo-18 percutaneous transluminal angioplasty (PTA) catheter, which is coated with a matrix of antiproliferative paclitaxel and a biocompatible excipient that enables an optimal drug transfer to the target lesion tissue. The Passeo-18 Lux includes a novel protective insertion aid to facilitate easier device introduction and handling. Read more